![](/wp-content/uploads/2024/02/877f0433-757b-4423-ba23-69b37b787e80.jpg)
$599
AZ and Viking Q4 ‘23 Earnings; Madrigal Publishes MAESTRO-NASH Results
Three cardiometabolic-related news items have been observed: AstraZeneca (press release; slides) and Viking Therapeutics (press release) hosted their respective Q4 ’23 earning calls; and Madrigal published Ph3 MAESTRO-NASH results in the NEJM (view press release). Below, FENIX provides highlights and insights for the respective news items.